Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_assertion type Assertion NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_head.
- NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_assertion description "[ERCC1 and TopoIIalpha are candidate markers in predicting clinical outcome and response to treatment in LD SCLC patients and are worth of further investigation in a prospective study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_provenance.
- NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_assertion evidence source_evidence_literature NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_provenance.
- NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_assertion SIO_000772 18520795 NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_provenance.
- NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_assertion wasDerivedFrom befree-20150227 NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_provenance.
- NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_assertion wasGeneratedBy ECO_0000203 NP381429.RAXamdLLijaPmhQdnH6vNu9z09fIzZ3hdPb84ckreSrE4130_provenance.